Skip to main content

Table 1 Laboratory data

From: Successful management of visceral disseminated varicella zoster virus infection during treatment of membranous nephropathy: a case report

Urinalysis/Blood test

Biochemistry/Immunological test/Coagulation test

Protein

±

TP

4.7 g/dL

HbA1c

5.0%

Occult blood

±

Alb

2.2 g/dL

TSH

1.344 μIU/mL

Red blood cell

1–4/HPF

UA

7.1 mg/dL

FT4

0.85 ng/dL

Protein content

0.42 g/gCr

BUN

8.6 mg/dL

IgG

452 mg/dL

Complete blood cell count

Cr

0.66 mg/dL

IgA

348 mg/dL

 White blood cell

10,600/μL

eGFR

81 mL/min/1.73 m2

IgM

118 mg/dL

 Neutrophil

9080 (85.8%)

TB

0.4 mg/dL

C3

89 mg/dL

 Lymphocyte

1190 (11.2%)

AST

105 IU/L

C4

15.1 mg/dL

 Monocyte

2.6%

ALT

92 IU/L

CH50

32 U/mL

 Eosinophil

0%

ALP

142 IU/L

Antinuclear Ab

1:80

 Red blood cell

418 × 104/μL

γ-GT

28 IU/L

Anti-dsDNA-Ab

(−)

 Hemoglobin

13.7 g/dL

LDH

581 IU/L

Anti-Sm-Ab

(−)

 Hematocrit

39.6%

CK

107 IU/L

Anti-MPO-ANCA

(−)

 Platelet

14.8 × 104/μL

Na

139 mEq/L

Anti-PR3-ANCA

(−)

K

4.0 mEq/L

PT

121%

Cl

104 mEq/L

PT-INR

0.9

cCa

9.7 mg/dL

APTT

29.7 s

IP

3.4 mg/dL

Fibrinogen

242 mg/dl

CRP

0.4 mg/dL

FDP

18.8 μg/ml

Glu

96 mg/dl

D-dimer

11.1 μg/ml

  1. TP total protein, Alb albumin, UA uric acid, BUN blood urea nitrogen, Cr creatinine, eGFR estimated glomerular filtration rate, TB total bilirubin, AST aspartic aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, γ-GT γ-glutamyltransferase, LDH lactate dehydrogenase, CK creatine kinase, Na sodium, K: potassium, Cl chlorine, cCa corrected calcium, IP inorganic phosphorus, CRP C-reactive protein, Glu glucose, HbA1c hemoglobin A1c, TSH thyroid stimulating hormone, FT4 free thyroxine, IgG immunoglobulin G, IgA immunoglobulin A, IgM immunoglobulin M, Ab antibody, dsDNA double-stranded DNA, Sm Smith, MPO-ANCA myeloperoxidase-anti-neutrophil cytoplasmic antibody, PR3-ANCA proteinase-3-anti-neutrophil cytoplasmic antibody, PT prothrombin time, PT-INR prothrombin time-international normalized ratio, APTT activated partial thromboplastin time, FDP fibrinogen degradation products